spacer
home > ict > winter 2015 > comment from the editor
PAY PER VIEW SERVICE

 

Dear guest!

article: Comment from the Editor
format: Adobe Acrobat PDF file
cost: £

spacer

 
News and Press Releases

Acino Signs Exclusive License Agreement With Bioprojet for Treatment of Narcolepsy and Obstructive Sleeping Apnoea (OSA)

ZURICH, Switzerland, 14 June 2022 Acino, a Swiss pharmaceutical company headquartered in Zurich, announced today that it has signed an exclusive licensing agreement with Bioprojet, a French research-based pharmaceutical company, to register, market, commercialise, and distribute pitolisant in the Kingdom of Saudi Arabia (KSA), with potential expansion to other countries in the Middle East.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement